A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

Micheal R. Grever, Jacqueline Benedetti, Stanley P. Balcerzak, Sarah A. Taylor, Thomas P. Miller, Shaker R. Dakhil

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)259-261
Number of pages3
JournalInvestigational New Drugs
Volume12
Issue number3
DOIs
StatePublished - Sep 1994

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Grever, M. R., Benedetti, J., Balcerzak, S. P., Taylor, S. A., Miller, T. P., & Dakhil, S. R. (1994). A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma. Investigational New Drugs, 12(3), 259-261. https://doi.org/10.1007/BF00873969